Literature DB >> 16842170

Effects of modafinil on cognitive performance and alertness during sleep deprivation.

Nancy J Wesensten1.   

Abstract

The performance- and alertness-sustaining/restoring effects of modafinil during sleep deprivation in normal, healthy adults were reviewed. Results indicate that modafinil is efficacious for sustaining/restoring objective performance and alertness during sleep deprivation with few adverse effects. At appropriate dosages, modafinil restores performance and alertness to non-sleep deprived levels. Modafinil also impairs post-sleep deprivation recovery sleep, but from the few studies available addressing this issue, it is unclear whether these sleep impairments translate into post-sleep performance impairments. Further research is needed to determine whether modafinil restores performance on simple cognitive tasks only or whether modafinil additionally restores executive functions (e.g., abstract thought, critical reasoning, planning, decision-making, situational awareness, and effective judgment) which are critical in most modern operational settings. In addition, studies are needed to determine whether modafinil use during sleep deprivation is preferable to that of other available controlled stimulants (such as dextroamphetamine) or non-controlled stimulants (such as caffeine). Such studies would be comprised of direct, head-to-head comparisons among various stimulants across a range of dosages.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842170     DOI: 10.2174/138161206777698819

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  11 in total

1.  Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study.

Authors:  Kathrin Finke; Chris M Dodds; Peter Bublak; Ralf Regenthal; Frank Baumann; Tom Manly; Ulrich Müller
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

Review 2.  [Options, limits and ethics of pharmacological neuroenhancement].

Authors:  C Normann; J Boldt; G Maio; M Berger
Journal:  Nervenarzt       Date:  2010-01       Impact factor: 1.214

3.  Effects of modafinil on the sleep EEG depend on Val158Met genotype of COMT.

Authors:  Sereina Bodenmann; Hans-Peter Landolt
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

4.  The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.

Authors:  Dawn E Sugarman; James Poling; Mehmet Sofuoglu
Journal:  Pharmacol Biochem Behav       Date:  2010-12-21       Impact factor: 3.533

5.  Metabolic response of the cerebral cortex following gentle sleep deprivation and modafinil administration.

Authors:  Jean-Marie Petit; Irene Tobler; Caroline Kopp; Florence Morgenthaler; Alexander A Borbély; Pierre J Magistretti
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

6.  Modulatory effects of modafinil on neural circuits regulating emotion and cognition.

Authors:  Roberta Rasetti; Venkata S Mattay; Beth Stankevich; Kelsey Skjei; Giuseppe Blasi; Fabio Sambataro; Isabel C Arrillaga-Romany; Terry E Goldberg; Joseph H Callicott; José A Apud; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2010-06-16       Impact factor: 7.853

Review 7.  The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.

Authors:  Maddalena Mereu; Antonello Bonci; Amy Hauck Newman; Gianluigi Tanda
Journal:  Psychopharmacology (Berl)       Date:  2013-08-10       Impact factor: 4.530

8.  Haloperidol attenuates Methylphenidate and Modafinil induced behavioural sensitization and cognitive enhancement.

Authors:  Nausheen Alam; Kulsoom Choudhary
Journal:  Metab Brain Dis       Date:  2018-02-22       Impact factor: 3.584

9.  The developing utility of zebrafish models for cognitive enhancers research.

Authors:  Adam Michael Stewart; Allan V Kalueff
Journal:  Curr Neuropharmacol       Date:  2012-09       Impact factor: 7.363

10.  Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons.

Authors:  Andreas G Franke; Christiana Bagusat; Pavel Dietz; Isabell Hoffmann; Perikles Simon; Rolf Ulrich; Klaus Lieb
Journal:  BMC Med       Date:  2013-04-09       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.